Applying New Targeted Approaches to Metastatic Colorectal Cancer CME

Author Information and Disclosures

Release Date: January 25, 2008; Valid for credit through January 25, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

The content of this CME activity, "Applying New Targeted Approaches to Metastatic Colorectal Cancer," was developed by the faculty.

To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
BMS, ImClone
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review necessary steps in the clinical evaluation of a patient with metastatic CRC
  2. Describe the indications for surgical resection in a patient with CRC with liver metastases
  3. Evaluate neoadjuvant and adjuvant chemotherapy options
  4. Compare and contrast treatment regimens for recurrent disease
Authors and Disclosures

Alan P. Venook, MD
Disclosure: Alan P. Venook, MD, has disclosed that he has received research funding from Genentech, Amgen, Pfizer, and Novartis.


Margie Miller
Disclosure: Margie Miller has disclosed no relevant financial relationships.


Ammar Hasan, PharmD
Disclosure: Ammar Hasan, PharmD, has disclosed no relevant financial relationships.


Jill W. Chamberlain
Disclosure: Jill W. Chamberlain has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.